NCT06152094Completed
UCSF BP Activate Letter Study
UCSF BP Activate Letter Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 28 Jan 2025
Brief summary (registry, in English)
The BP Activate Study aims to assess the effectiveness of the BP Report letter with personalized BP medication recommendations, compared with Control letters and no intervention, at shortening time to appointment, time to visit, time to medication change, and time to achievement of BP goal.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 484 (actual)
- First submitted
- 21 Nov 2023
- Start date
- 20 Jul 2023
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- University of California, San Francisco
- Diseases
- High blood pressure
- NCT number
- NCT06152094
What you commit to
- Study type: Interventional
- Participants enrolled: 484
- From 20 Jul 2023 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Primary language is not English
- Patient's provider indicates (through an active opt-out process) that they do not want the patient to receive a BP Activate letter
Who the study is looking for
- Patient is a primary care patient of a clinician in a general internal medicine clinic who has agreed to have their patients participate in the study
- Lowest SBP\>140 or lowest DBP\>90 at last visit in general internal medicine clinic
- Last visit in general internal medicine clinic was \< 2 years ago
- EngageRx algorithm determines that a medication intensification step is indicated
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.